December 21, 2025
11 11 11 AM
US seizes second oil tanker off Venezuela’s coast
Reality TV Couples: Who Got Together and Who Broke Up in 2025
Star Sightings: Melissa McCarthy Hosts ‘Saturday Night Live’, Charlie Hunnam Attends a Holiday Pary in L.A.
Avatar Secrets That Won’t Make You Blue
EU agree €90bn loan for Ukraine but without using Russian assets
Access Italy Co-Founder Simone Amorico Shares Why Stars Trust Him to Plan Their Dream Vacations
Inside the Love Lives of Emily in Paris Stars
‘Maybe she’s an angel now’ says aunt of 10-year-old Bondi victim
These Secrets About The Simpsons Will Make You Say Ay Caramba!
These Secrets About The Family Stone Will Get Your Freak Flag Flying
Latest Post
US seizes second oil tanker off Venezuela’s coast Reality TV Couples: Who Got Together and Who Broke Up in 2025 Star Sightings: Melissa McCarthy Hosts ‘Saturday Night Live’, Charlie Hunnam Attends a Holiday Pary in L.A. Avatar Secrets That Won’t Make You Blue EU agree €90bn loan for Ukraine but without using Russian assets Access Italy Co-Founder Simone Amorico Shares Why Stars Trust Him to Plan Their Dream Vacations Inside the Love Lives of Emily in Paris Stars ‘Maybe she’s an angel now’ says aunt of 10-year-old Bondi victim These Secrets About The Simpsons Will Make You Say Ay Caramba! These Secrets About The Family Stone Will Get Your Freak Flag Flying

Intranasal vaccine against H5 avian flu provokes broad immune response in adults in phase 1 trial

Three of five groups of eight participants each received low, medium, or high doses of the clade 2.1 influenza A/H5 (A/Indonesia/05/2005) recombinant hemagglutinin glycoprotein (rH5) vaccine combined with an adjuvant; one group received 100 µg of an unadjuvanted rH5 vaccine; and one group received placebo. All participants received an intramuscular H5 booster 6 months later.

Participants who received the adjuvanted vaccine had higher levels of protective antibodies (immunoglobulin [Ig] G and A), more memory immune cells, and a better ability to neutralize infected cells.

Only recipients of the boosted intranasal vaccine showed strong immune priming. Even without a booster, the intranasal vaccine triggered mucosal and systemic immunity, which other intranasal recombinant H5 flu vaccines have not achieved in clinical trials. It also was safe and well-tolerated.

The immune system’s ability to recognize multiple strains of H5N1 virus is key because they change over time, co-lead author Meagan Deming, MD, PhD, said in a university news release. “The use of the adjuvant also suggests this approach might allow for lower doses of the vaccine, which could make our current vaccine stocks available to more people in the event of an outbreak,” she said.

Corresponding author Justin Ortiz, MD, said that global transmission of H5N1 in animals, including spillover into people, underscores the need for effective countermeasures. “This trial shows that this intranasal, shelf-stable H5N1 vaccine could play a major role in pandemic preparedness, offering a practical and scalable way to help protect people from evolving strains of the virus,” he said.

10 thoughts on “Intranasal vaccine against H5 avian flu provokes broad immune response in adults in phase 1 trial

  1. Your blog is a testament to your dedication to your craft. Your commitment to excellence is evident in every aspect of your writing. Thank you for being such a positive influence in the online community.

  2. I just wanted to drop by and say how much I appreciate your blog. Your writing style is both engaging and informative, making it a pleasure to read. Looking forward to your future posts!

  3. Hello Neat post Theres an issue together with your site in internet explorer would check this IE still is the marketplace chief and a large element of other folks will leave out your magnificent writing due to this problem

  4. Your blog is a testament to your dedication to your craft. Your commitment to excellence is evident in every aspect of your writing. Thank you for being such a positive influence in the online community.

Leave a Reply

Your email address will not be published. Required fields are marked *